Teva Pharmaceutical Industries (TEVA)
(Delayed Data from NYSE)
$12.78 USD
-0.40 (-3.03%)
Updated Apr 18, 2024 04:00 PM ET
After-Market: $12.79 +0.01 (0.08%) 7:58 PM ET
3-Hold of 5 3
A Value A Growth B Momentum A VGM
Industry / Sector Report
Industry : Medical - Generic Drugs
Zacks Industry Rank
Bottom 36% (160 out of 251)Zacks Sector Rank
Top 13% (2 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.60 | 1.42 | 9.99 |
Current Quarter Estimate | 0.51 | 1.25 | 60.00 |
Year Ago Quarter Estimate | 0.40 | -4.28 | 52.54 |
Next Quarter Estimate | 0.58 | 1.37 | 61.00 |
Next Year Estimate | 2.61 | 7.08 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -7.42 | 21.70 | 17.08 |
Next Year | 10.13 | 11.50 | 8.00 |
Last 5 Years | -4.00 | 0.80 | 8.10 |
Next 5 Years | 3.70 | 8.50 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 5.15 | 1.64 |
Price/Book (MRQ) | 1.82 | 1.20 |
Price/Cash Flow (MRFY) | 3.75 | 9.97 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -3.33% | NA |
Return on Equity (TTM) | 34.90% | NA |
Debt to Equity (MRQ) | NA | NA |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.